Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway
L Wang, X Cai, M Shi, L Xue, S Kuang, R Xu… - European journal of …, 2020 - Elsevier
Parkinson's disease (PD) is a slowly progressive and complex neurodegenerative disorder.
Up to date, there are no approved drugs that could slow or reverse the neurodegenerative …
Up to date, there are no approved drugs that could slow or reverse the neurodegenerative …
Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway.
L Wang, X Cai, M Shi, L Xue, S Kuang… - European Journal of …, 2020 - europepmc.org
Parkinson's disease (PD) is a slowly progressive and complex neurodegenerative disorder.
Up to date, there are no approved drugs that could slow or reverse the neurodegenerative …
Up to date, there are no approved drugs that could slow or reverse the neurodegenerative …
Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway
L Wang, X Cai, M Shi, L Xue… - European journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is a slowly progressive and complex neurodegenerative disorder.
Up to date, there are no approved drugs that could slow or reverse the neurodegenerative …
Up to date, there are no approved drugs that could slow or reverse the neurodegenerative …